Insurance Reimbursement Challenges for High-Quality Medications in China

Recently, a colleague took their mother, who had a fracture, to see a doctor and said:
“Can we use the best medications and imported steel plates? Cost is not an issue—we have insurance.”


The doctor could only shake their head with a bitter smile.


This scenario may not be an isolated case. Even with insurance, accessing high-quality medications seems increasingly difficult…



1. High-Quality Medications Are Often Outside Hospitals


In China, medications account for the largest portion of medical expenses.


In July 2019, Professor Liu Guoen from Peking University mentioned that Chinese patients spend approximately 30–40% of their medical costs on medications, ranking among the highest globally.


This figure is likely an average. For many cancer patients, monthly targeted therapy costs range from thousands to tens of thousands of yuan, lasting for years, forming the core financial burden of treatment…



“Dying to Survive” (“I Am Not Madame Bovary”)


Many hoped that after negotiations, these medications would become affordable. However, some drugs quietly disappeared from hospitals, leaving patients to purchase them out-of-pocket at external pharmacies.


Fortunately, there has been a turning point.


Many regions have implemented the”dual-channel” policy, allowing patients to purchasemedications unavailable in hospitals at designated pharmacies, reimbursed under the samepolicy.


It is hoped this policy will soon be implemented nationwide, alleviating medication access challenges.


However, these are stillmedications. Access to more effective, lower-side-effect imported ordrugs remains difficult.



Currently, hospitals either lack these medications or have limited supplies, often reserved for critical orpatients, leavingpatients without access.


Another colleague underwent eye surgery last month. The doctor recommended an imported eye drop costing over 60 yuan per bottle, but it was unavailable in the hospital and had to be purchased externally.


While 60 yuan may seem insignificant, it reflects a broader trend.


If hospitals no longer stock such medications, accessing more expensive, high-quality drugs costing thousands or tens of thousands of yuan will likely become even harder.



With the full implementation of DRG/DIP and strictercost controls, out-of-hospital medication purchases will become more frequent.


So, can ourreimburse these out-of-hospital medications?



2. Two Out-of-Hospital Medications Denied Reimbursement for Cancer Patient


In 2022, a lung cancer patient was advised by their doctor to use two targeted therapies: pyrotinib and paclitaxel (albumin-bound).


Both required out-of-hospital purchases, but thedenied reimbursement for different reasons.


Pyrotinib was on the out-of-hospital medication list, but according toguidelines, it is only approved for breast cancer.


The doctor explained that this medication has the best sample size data, and the patient’s specific cancer mutation type can only be treated with this drug. If it were ineffective against lung cancer, they would not prescribe it, as patient health is not to be taken lightly.



However, the million-yuan medical insurance explicitly states that externally purchased oncology drugs must comply with the indications approved by the drug regulatory authority, leading to the claim denial.



From a third-party perspective, the drug regulatory authority aims to standardize usage and prevent abuse, doctors prioritize treatment efficacy, and insurers aim to prevent fraud. No party is at fault.



Yet, reality evolves faster than written regulations, and patients ultimately bear the consequences.



After negotiations, the medication was switched to durvalumab, another lung cancer targeted therapy, and the claim was approved.



In other cases, claims were approved without changing medications, provided the doctor submitted sufficient documentation. Claim outcomes depend not only on policy terms but also on the insurer.



As for the second drug, paclitaxel (albumin-bound), it was not on the approved drug list, making reimbursement impossible regardless of negotiations.



This limitation applies not only to the case’s million-yuan medical insurance but also to well-known products like Good Health Insurance 20-Year, Blue Medical Insurance, and Changxiang’an:



– They cover over 100 specialized oncology drugs and 2 CAR-T therapies, excluding off-list medications.


– Policy terms explicitly require compliance with approved indications and dosages.



Deviations from these requirements often lead to claim disputes.



Given that million-yuan medical insurance costs as little as a few hundred yuan annually, expecting it to solve all medical challenges is unrealistic.



3. Upgrading Million-Yuan Medical Insurance



Beyond basic oncology drug coverage, some products offer better external medication benefits. Here are two examples:



1. **Coverage for Anticancer + Other Medications**


For instance, Zunxiang e-Sheng 2024 covers 108 oncology drugs, plus 30 rare disease medications, 15 specific imported drugs, and 10 designated disease treatments.



Zunxiang e-Sheng 2024


ZhongAn Online P&C Insurance


Medical Insurance


Optional benefits


External medication coverage


View review



The 10 designated drugs include human albumin and paclitaxel injections.



The only concern is its non-guaranteed annual renewal. However, no cases of post-claim renewal denials have been reported, and its large policyholder base suggests stable renewal prospects.



Additionally, it continuously updates to provide broader treatment options and more comprehensive drug coverage.


If you are genuinely concerned about renewal issues, you can purchase a guaranteed renewal product as a supplement.



2. No Medication List Restrictions


For example, the “Good Health Insurance·Long-term Medical (0 Deductible)” on Alipay, which guarantees renewal for 6 years, has no restrictions on externally purchased medications, and this is explicitly stated in the terms. However, purchases must be made at designated pharmacies.


If your older version of “Good Health Insurance·Long-term Medical” is nearing expiration and you value coverage for externally purchased medications, you may consider upgrading to this product.


On the other hand, “Good Health Insurance (20-year Version)” and “Good Health Insurance (Flagship Version)” have medication list restrictions, making them more suitable for those prioritizing renewal conditions.



3. No Directory Restrictions, Coverage for Externally Purchased Medications and Equipment


For instance, the following two mid-to-high-end medical insurance products not only cover externally purchased medications without directory restrictions but also reimburse externally purchased medical materials and equipment, including higher-quality plates, cardiac stents, etc., achieving true “medication freedom.”


Beyond medication freedom, mid-to-high-end medical insurance also provides better medical resources and healthcare services.


When facing serious illnesses, most people don’t know where to go or which doctor to consult, even if they do, they often lack access to such medical resources.


Mid-to-high-end medical insurance products typically have their own medical teams to help select suitable hospitals and top-tier doctors, arranging appointments, hospitalization, surgery, and reimbursement as a seamless process.


These products not only address the issue of “high medical costs” but more importantly, solve the problem of “difficulty accessing healthcare.”


Both of the above products feature a 0 deductible, making them relatively expensive. For more affordable options, consider versions with deductibles. For example, “MSH Enjoy Life 2023” has a 30,000 deductible, costing only 1,075 yuan annually for a 30-year-old adult.



MSH Enjoy Life 2023


Dadi Property & Casualty Insurance


Medical Insurance


Up to 6 million coverage


Includes special departments and private hospitals


Mid-to-high-end medical insurance


View evaluation


There’s no need to worry about high out-of-pocket expenses, as this product features a “relative deductible”: portions covered by social insurance can also be used to offset the deductible.


Mid-to-high-end medical insurance is relatively complex, requiring attention not only to coverage but also to the network of hospitals and the service capabilities behind them. If interested, you can click the card at the end to schedule a consultation with an advisor.


As for the “indication” challenges of specialized cancer drugs, these are difficult to resolve. Even without list restrictions, there will still be “reasonable and necessary” requirements.


Therefore, in such cases, it’s crucial to communicate in advance with the insurance company and doctors to avoid incurring significant out-of-pocket expenses.



4. Final Notes


The principle of medical insurance has always been “basic coverage,” making it difficult to include high-quality or expensive medications.


After all, the pool of resources is limited. If one person spends more, others will have less to use…



High-quality medical resources are equally scarce, accessible only to a select few.



In such circumstances, those with the means should prepare adequately, such as by opting for mid-to-high-end medical insurance with better coverage.



Finally, we strongly recommend having critical illness insurance. The payout from this insurance can be used as you see fit, without any restrictions, giving you more options during serious illnesses.



If you wish to customize a dedicated family protection plan for yourself and your loved ones, click the card below to start planning immediately.


Leave a Comment

Your email address will not be published. Required fields are marked *